(HRL) Hormel Foods - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US4404521001
Stock: Meats, Nuts, Frozen, Canned, Snacks
Total Rating 37
Risk 97
Buy Signal -0.61
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.41% |
| Yield on Cost 5y | 2.73% |
| Yield CAGR 5y | 4.31% |
| Payout Consistency | 96.7% |
| Payout Ratio | 84.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 23.7% |
| Relative Tail Risk | -5.83% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.45 |
| Alpha | -15.74 |
| Character TTM | |
|---|---|
| Beta | 0.057 |
| Beta Downside | -0.067 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.62% |
| CAGR/Max DD | -0.31 |
Description: HRL Hormel Foods January 03, 2026
Hormel Foods Corp. (HRL) manufactures, processes, and distributes a broad portfolio of meat, nut, and other food products to retail, food-service, and international customers. The business is organized into three segments-Retail, Foodservice, and International-and offers both perishable items (e.g., bacon, refrigerated meals, guacamole) and shelf-stable goods (e.g., canned meats, nut butters, microwaveable meals). Its brands include Hormel, Spam, Skippy, and many private-label lines, sold through a mix of direct sales, brokers, and distributors.
Key operating metrics: FY2023 net sales were approximately $12.6 billion, with an adjusted operating margin of ~12%, reflecting steady pricing power despite higher commodity costs. The protein sector is driven by rising consumer demand for convenient, high-protein meals and by volatile livestock prices, which together affect gross margins. Additionally, inflationary pressure on discretionary food spending and the ongoing shift toward private-label alternatives are important macro-economic headwinds for the packaged-foods industry.
For a deeper, data-rich look at Hormel’s valuation and peer comparison, check out the ValueRay analysis.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 478.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -3.53 > 1.0 |
| NWC/Revenue: 16.73% < 20% (prev 15.50%; Δ 1.23% < -1%) |
| CFO/TA 0.06 > 3% & CFO 845.2m > Net Income 478.2m |
| Net Debt (2.19b) to EBITDA (1.01b): 2.18 < 3 |
| Current Ratio: 2.47 > 1.5 & < 3 |
| Outstanding Shares: last quarter (550.5m) vs 12m ago 0.19% < -2% |
| Gross Margin: 15.63% > 18% (prev 0.17%; Δ 1546 % > 0.5%) |
| Asset Turnover: 90.25% > 50% (prev 88.73%; Δ 1.52% > 0%) |
| Interest Coverage Ratio: 9.50 > 6 (EBITDA TTM 1.01b / Interest Expense TTM 78.0m) |
Altman Z'' 4.59
| A: 0.15 (Total Current Assets 3.41b - Total Current Liabilities 1.38b) / Total Assets 13.39b |
| B: 0.56 (Retained Earnings 7.52b / Total Assets 13.39b) |
| C: 0.06 (EBIT TTM 741.5m / Avg Total Assets 13.41b) |
| D: 1.33 (Book Value of Equity 7.28b / Total Liabilities 5.48b) |
| Altman-Z'' Score: 4.59 = AA |
Beneish M -3.07
| DSRI: 0.89 (Receivables 784.8m/868.3m, Revenue 12.11b/11.92b) |
| GMI: 1.09 (GM 15.63% / 16.96%) |
| AQI: 0.97 (AQ_t 0.58 / AQ_t-1 0.59) |
| SGI: 1.02 (Revenue 12.11b / 11.92b) |
| TATA: -0.03 (NI 478.2m - CFO 845.2m) / TA 13.39b) |
| Beneish M-Score: -3.07 (Cap -4..+1) = AA |
What is the price of HRL shares?
As of February 07, 2026, the stock is trading at USD 24.93 with a total of 3,403,092 shares traded.
Over the past week, the price has changed by +1.30%, over one month by +10.49%, over three months by +16.24% and over the past year by -10.71%.
Over the past week, the price has changed by +1.30%, over one month by +10.49%, over three months by +16.24% and over the past year by -10.71%.
Is HRL a buy, sell or hold?
Hormel Foods has received a consensus analysts rating of 3.25.
Therefor, it is recommend to hold HRL.
- StrongBuy: 1
- Buy: 1
- Hold: 10
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the HRL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 27.3 | 9.3% |
| Analysts Target Price | 27.3 | 9.3% |
| ValueRay Target Price | 25.2 | 1.1% |
HRL Fundamental Data Overview February 04, 2026
P/E Trailing = 28.1149
P/E Forward = 17.2117
P/S = 1.1115
P/B = 1.7134
P/EG = 1.679
Revenue TTM = 12.11b USD
EBIT TTM = 741.5m USD
EBITDA TTM = 1.01b USD
Long Term Debt = 2.85b USD (from longTermDebt, last quarter)
Short Term Debt = 6.65m USD (from shortTermDebt, last quarter)
Debt = 2.86b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.19b USD (from netDebt column, last quarter)
Enterprise Value = 15.64b USD (13.46b + Debt 2.86b - CCE 670.7m)
Interest Coverage Ratio = 9.50 (Ebit TTM 741.5m / Interest Expense TTM 78.0m)
EV/FCF = 29.27x (Enterprise Value 15.64b / FCF TTM 534.4m)
FCF Yield = 3.42% (FCF TTM 534.4m / Enterprise Value 15.64b)
FCF Margin = 4.41% (FCF TTM 534.4m / Revenue TTM 12.11b)
Net Margin = 3.95% (Net Income TTM 478.2m / Revenue TTM 12.11b)
Gross Margin = 15.63% ((Revenue TTM 12.11b - Cost of Revenue TTM 10.21b) / Revenue TTM)
Gross Margin QoQ = 13.96% (prev 16.07%)
Tobins Q-Ratio = 1.17 (Enterprise Value 15.64b / Total Assets 13.39b)
Interest Expense / Debt = 0.69% (Interest Expense 19.6m / Debt 2.86b)
Taxrate = 27.99% (185.7m / 663.4m)
NOPAT = 534.0m (EBIT 741.5m * (1 - 27.99%))
Current Ratio = 2.47 (Total Current Assets 3.41b / Total Current Liabilities 1.38b)
Debt / Equity = 0.36 (Debt 2.86b / totalStockholderEquity, last quarter 7.90b)
Debt / EBITDA = 2.18 (Net Debt 2.19b / EBITDA 1.01b)
Debt / FCF = 4.09 (Net Debt 2.19b / FCF TTM 534.4m)
Total Stockholder Equity = 8.01b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.56% (Net Income 478.2m / Total Assets 13.39b)
RoE = 5.97% (Net Income TTM 478.2m / Total Stockholder Equity 8.01b)
RoCE = 6.83% (EBIT 741.5m / Capital Employed (Equity 8.01b + L.T.Debt 2.85b))
RoIC = 4.91% (NOPAT 534.0m / Invested Capital 10.87b)
WACC = 5.13% (E(13.46b)/V(16.31b) * Re(6.12%) + D(2.86b)/V(16.31b) * Rd(0.69%) * (1-Tc(0.28)))
Discount Rate = 6.12% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 0.21%
[DCF Debug] Terminal Value 85.06% ; FCFF base≈724.7m ; Y1≈643.6m ; Y5≈537.6m
Fair Price DCF = 25.61 (EV 16.27b - Net Debt 2.19b = Equity 14.09b / Shares 550.1m; r=5.90% [WACC]; 5y FCF grow -13.76% → 2.90% )
EPS Correlation: -81.12 | EPS CAGR: -8.14% | SUE: 0.52 | # QB: 0
Revenue Correlation: -15.52 | Revenue CAGR: 1.22% | SUE: -0.63 | # QB: 0
EPS next Quarter (2026-04-30): EPS=0.35 | Chg30d=+0.008 | Revisions Net=+0 | Analysts=7
EPS current Year (2026-10-31): EPS=1.46 | Chg30d=+0.000 | Revisions Net=+1 | Growth EPS=+6.9% | Growth Revenue=+2.3%
EPS next Year (2027-10-31): EPS=1.56 | Chg30d=-0.001 | Revisions Net=-2 | Growth EPS=+6.3% | Growth Revenue=+2.2%
P/E Forward = 17.2117
P/S = 1.1115
P/B = 1.7134
P/EG = 1.679
Revenue TTM = 12.11b USD
EBIT TTM = 741.5m USD
EBITDA TTM = 1.01b USD
Long Term Debt = 2.85b USD (from longTermDebt, last quarter)
Short Term Debt = 6.65m USD (from shortTermDebt, last quarter)
Debt = 2.86b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.19b USD (from netDebt column, last quarter)
Enterprise Value = 15.64b USD (13.46b + Debt 2.86b - CCE 670.7m)
Interest Coverage Ratio = 9.50 (Ebit TTM 741.5m / Interest Expense TTM 78.0m)
EV/FCF = 29.27x (Enterprise Value 15.64b / FCF TTM 534.4m)
FCF Yield = 3.42% (FCF TTM 534.4m / Enterprise Value 15.64b)
FCF Margin = 4.41% (FCF TTM 534.4m / Revenue TTM 12.11b)
Net Margin = 3.95% (Net Income TTM 478.2m / Revenue TTM 12.11b)
Gross Margin = 15.63% ((Revenue TTM 12.11b - Cost of Revenue TTM 10.21b) / Revenue TTM)
Gross Margin QoQ = 13.96% (prev 16.07%)
Tobins Q-Ratio = 1.17 (Enterprise Value 15.64b / Total Assets 13.39b)
Interest Expense / Debt = 0.69% (Interest Expense 19.6m / Debt 2.86b)
Taxrate = 27.99% (185.7m / 663.4m)
NOPAT = 534.0m (EBIT 741.5m * (1 - 27.99%))
Current Ratio = 2.47 (Total Current Assets 3.41b / Total Current Liabilities 1.38b)
Debt / Equity = 0.36 (Debt 2.86b / totalStockholderEquity, last quarter 7.90b)
Debt / EBITDA = 2.18 (Net Debt 2.19b / EBITDA 1.01b)
Debt / FCF = 4.09 (Net Debt 2.19b / FCF TTM 534.4m)
Total Stockholder Equity = 8.01b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.56% (Net Income 478.2m / Total Assets 13.39b)
RoE = 5.97% (Net Income TTM 478.2m / Total Stockholder Equity 8.01b)
RoCE = 6.83% (EBIT 741.5m / Capital Employed (Equity 8.01b + L.T.Debt 2.85b))
RoIC = 4.91% (NOPAT 534.0m / Invested Capital 10.87b)
WACC = 5.13% (E(13.46b)/V(16.31b) * Re(6.12%) + D(2.86b)/V(16.31b) * Rd(0.69%) * (1-Tc(0.28)))
Discount Rate = 6.12% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 0.21%
[DCF Debug] Terminal Value 85.06% ; FCFF base≈724.7m ; Y1≈643.6m ; Y5≈537.6m
Fair Price DCF = 25.61 (EV 16.27b - Net Debt 2.19b = Equity 14.09b / Shares 550.1m; r=5.90% [WACC]; 5y FCF grow -13.76% → 2.90% )
EPS Correlation: -81.12 | EPS CAGR: -8.14% | SUE: 0.52 | # QB: 0
Revenue Correlation: -15.52 | Revenue CAGR: 1.22% | SUE: -0.63 | # QB: 0
EPS next Quarter (2026-04-30): EPS=0.35 | Chg30d=+0.008 | Revisions Net=+0 | Analysts=7
EPS current Year (2026-10-31): EPS=1.46 | Chg30d=+0.000 | Revisions Net=+1 | Growth EPS=+6.9% | Growth Revenue=+2.3%
EPS next Year (2027-10-31): EPS=1.56 | Chg30d=-0.001 | Revisions Net=-2 | Growth EPS=+6.3% | Growth Revenue=+2.2%